Company: PETVW
Filing Date: 2025-07-10
Form Type: 10-K
Source: 0001641172-25-018617
Chunk: 21

Company: PetVivo Holdings, Inc.
Filing Date: 2025-07-10
Form: 10-K
Item: Item 1
Chunk 21
---
 beyond what is necessary to fund our ongoing
operations and pay our obligations as they become due. We may never generate revenues sufficient to become profitable or to sustain profitability.

14

If
we are unable to obtain sufficient funding, we may have to reduce materially or even discontinue our business.

As
of March 31, 2025, we have cash or cash equivalents of approximately $228,000. We anticipate that we will be adequate to satisfy operational
and capital requirements for the next one (1) month. If we are unable to realize substantial revenues in the near future, we will need
to seek additional financing beyond this three-month period to continue our operations. We also most likely will require additional financing
to develop additional new products or to expand into foreign markets. Accordingly, our ability to commercialize Spryng®
and other products may be dependent on our receipt of the net proceeds from our future financings. We also had an investor subscribe
to a $5 million Series B Preferred stock offering whereby $600,000 has been received by March 31, 2025. The remaining $4.4 million is
expected to be received just prior to the filing of this Form 10-K.

Along
with establishing effective production, marketing, sales, and distribution of Spryng® and other products, we believe that
our future capital requirements depend upon the timing and costs of many factors with some of them beyond our control, including our
ability to establish an adequate base of veterinarian clinics using our products, costs in obtaining patents and any required regulatory
approvals for future products, costs of any future target animal studies, costs related to new product development, costs of finished
product inventory, expenses to attract and retain skilled personnel as needed, increased costs related to being a listed public company,
and the costs of any future acquisitions of existing companies or IP technologies. There is no assurance that future additional capital
will be available to us as needed, or if available upon terms acceptable to us.

Risks
Relating to Our Business and Industry

We
have a limited operating history upon which to base an evaluation of our business prospects.

We
were incorporated in March 2009 and have a limited operating history upon which to base an evaluation of our business prospects. We did
not begin generating notable revenues from the sale of Spryng® until the second quarter of fiscal 2023. Our limited operating
history makes an evaluation of our business and prospects very difficult. Our prospects must be considered speculative, especially